[Mechanism of action, indications and problems in using aethoxysklerol as a sclerosing agent in esophageal varices].
Nishimura
S
S
First Department of Internal Medicine, Yamaguchi University School of Medicine.
Yoshida
T
T
Okita
K
K
D000818:Animals; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D006801:Humans; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000494:pharmacology / Q000627:therapeutic use*; D012597:Sclerosing Solutions / Q000494:pharmacology / Q000627:therapeutic use*; D015911:Sclerotherapy
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols